Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02IXC
|
||||
| Former ID |
DNC005746
|
||||
| Drug Name |
D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Asp-NH2
|
||||
| Indication | Discovery agent | Investigative | [527802] | ||
| Formula |
C50H65N11O11S2
|
||||
| Canonical SMILES |
CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC<br />CCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=C<br />C=C5)N)C(=O)NC(CC(=O)O)C(=O)N
|
||||
| InChI |
1S/C50H65N11O11S2/c1-27(2)42-50(72)60-40(48(70)56-36(43(53)65)23-41(63)64)26-74-73-25-39(59-44(66)33(52)20-28-10-4-3-5-11-28)49(71)57-37(21-29-15-17-31(62)18-16-29)46(68)58-38(22-30-24-54-34-13-7-6-12-32(30)34)47(69)55-35(45(67)61-42)14-8-9-19-51/h3-7,10-13,15-18,24,27,33,35-40,42,54,62H,8-9,14,19-23,25-26,51-52H2,1-2H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,71)(H,58,68)(H,59,66)(H,60,72)(H,61,67)(H,63,64)/t33-,35-,36-,37-,38+,39-,40+,42+/m0/s1
|
||||
| InChIKey |
HFLJXACCXCUGOQ-OZHBEKPPSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Somatostatin receptor type 5 | Target Info | Inhibitor | [527802] | |
| Somatostatin receptor type 2 | Target Info | Inhibitor | [527802] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| References | |||||